Tomasz Berchiet is a graduate of European Studies at the Faculty of Law and Administration of Nicolaus Copernicus University in Toruń, he is the founder of GRUPA4, where he oversees project team coordination, information flow, and internal process optimization. As a Management Board member, he focuses on operational efficiency, service quality, and effective resource management. Before establishing GRUPA4 in 2015, he served as Deputy Chairman of the Evaluation Committee at a Regional Financing Institution in the Mazowieckie region, implementing programs for the Polish Agency for Enterprise Development.

As an operational leader, he specializes in delivering and scaling complex R&D and investment projects across high-innovation sectors, including biotechnology, medtech, advanced materials, gaming technologies, and retail solutions. He combines experience from both the project evaluation and execution sides, enabling precise risk identification, effective decision-making, and successful delivery of complex, multi-stakeholder initiatives.

Magdalena Kołodziejska  is a senior executive with over 20 years of experience in strategic financial management within large capital groups, as well as in overseeing innovative projects and green transformation initiatives. She has built her professional career primarily within the broadly defined energy sector, where she was responsible for, among others, strategy development and execution, restructuring processes, corporate governance, acquisition and settlement of EU funding, and capital raising. Her professional focus has consistently been on financial and strategic domains.

Previously, she was associated with Polska Grupa Biogazowa (part of TotalEnergies), where she led the group’s exit from the Polski Fundusz Rozwoju investment, as well as the acquisition of the group by TotalEnergies, including post-merger integration. She also contributed to the development of TotalEnergies’ financial and investment strategy for Poland through 2030. In addition, she served as a Supervisory Board Member at DCX Innovation (developer of the CityScanner solution in Poland and Europe) and as a Management Board Member within the Wydawnictwo Naukowe PWN capital group.

She is a graduate of SGH Warsaw School of Economics, holding a Master’s degree in Finance and Banking, as well as a postgraduate diploma in European Union studies. She is currently a PhD candidate in Finance at the SGH Doctoral School.

On November 12, 2024, she was appointed Deputy Director of the National Centre for Research and Development for a four-year term.

Zbigniew Leś is an expert with over 20 years of experience in technology, life sciences, and the commercialization of scientific innovation. Currently Director of R&D Partnerships & Technology Transfer at The Heart, where he develops collaborations with universities and research institutions and supports the process of technology transfer and bringing breakthrough scientific solutions to market.

Previously CEO of Evidence Prime, a spin-off of McMaster University developing tools for evidence-based medicine, and held managerial positions at Orphinic Scientific and Laser Analytica (Certara). His experience includes the development of technology products as well as building collaborations between academia, industry, and startups.

Dr. Eng. Kinga Matuła is the CEO and co-founder of QurieGen, a Dutch-Polish biotech spin-off from Radboud University (Huck Lab), and a Venture Capital Analyst. With over 15 years of experience across biotechnology, physical chemistry, and translational research, she operates at the intersection of science, entrepreneurship, and investment, combining deep technical expertise with hands-on company-building experience.  Kinga’s mission is deeply personal. Having grown up around healthcare and later experiencing cancer as a patient herself, she is driven by a commitment to developing technologies that meaningfully improve patient outcomes.

Dr. Łukasz Rąbalski is the co-founder and CEO of Vaxican Sp. z o.o., a spin-off of the University of Gdańsk specializing in the development of next-generation vaccines based on VLP platforms, including therapeutic cancer vaccines. He serves as an assistant professor at the Intercollegiate Faculty of Biotechnology of the University of Gdańsk and the Medical University of Gdańsk. He is the author of over 50 scientific publications and a recipient of the Minister of Education and Science Award (2023) as well as the CEBioForum Jury Award (2025). He is also a graduate of the Clinical Scholars Research Training program at Harvard Medical School. Dr. Rąbalski is a United Nations (UNSGM) expert on biological weapons. He conducted the first genome sequencing in Poland of the SARS-CoV-2 virus isolated directly from a patient.